共同药业

300966 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

2.3B ($334.7M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

537.0M

Net Income

-31.7M

Gross Margin

N/A

Op. Margin

-7.9%

Net Margin

-5.9%

ROE

-3.1%

ROA

-1.1%

D/E

1.75

Dividend Yield

N/A

EPS

-0.24

Current Ratio

0.95

Price History

Company Info

Industry	C27医药制造业
Market Segment	ChiNext
Currency	CNY
Fiscal Year	2024

Business Overview

Hubei Goto Biopharm Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of steroid drug raw materials in China and internationally. It offers starting materials, intermediates, and other pharmaceutical raw materials. The company was founded in 2006 and is based in Xiangyang, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 共同药业

Ticker	300966
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业